Literature DB >> 23525613

Objective criteria for crohn-like lymphoid reaction in colorectal cancer.

Hideki Ueno1, Yojiro Hashiguchi, Hideyuki Shimazaki, Eiji Shinto, Yoshiki Kajiwara, Kuniaki Nakanishi, Kei Kato, Kazuya Maekawa, Kosuke Miyai, Takahiro Nakamura, Junji Yamamoto, Kazuo Hase.   

Abstract

We aimed to determine semiquantitative evaluation criteria for Crohn-like lymphoid reaction (CLR). We reviewed 1,032 patients with colorectal cancer and evaluated CLR by counting all peritumoral lymphoid aggregates (LAs) and by measuring the maximum diameter of the largest LA. The maximum diameter of the largest LA, rather than the number, had a significant impact on survival. Active CLR determined by the 1-mm rule was significantly associated with MLH1/MSH2 immunohistochemical staining deficiency. The group with LAs 1 mm or larger had lower recurrence (P = .0008) and a higher survival rate (P < .0001) than that without LAs 1 mm or larger. These results were similarly observed in another cohort of 500 patients with colorectal cancer. The k values for CLR evaluation among 8 observers were 0.67 for the 1-mm rule and 0.50 for Graham's criteria. The size of the largest LA best reflects the specific characteristics of CLR, and the 1-mm rule is expected to improve assessment reproducibility.

Entities:  

Mesh:

Year:  2013        PMID: 23525613     DOI: 10.1309/AJCPWHUEFTGBWKE4

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  19 in total

1.  Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic Markers.

Authors:  Tsuyoshi Konishi; Yoshifumi Shimada; Lik Hang Lee; Marcela S Cavalcanti; Meier Hsu; Jesse Joshua Smith; Garrett M Nash; Larissa K Temple; José G Guillem; Philip B Paty; Julio Garcia-Aguilar; Efsevia Vakiani; Mithat Gonen; Jinru Shia; Martin R Weiser
Journal:  Am J Surg Pathol       Date:  2018-06       Impact factor: 6.394

2.  Tertiary lymphoid structures in epithelioid malignant peritoneal mesothelioma are associated with neoadjuvant chemotherapy, but not with prognosis.

Authors:  Nazim Benzerdjeb; Peggy Dartigues; Vahan Kepenekian; Séverine Valmary-Degano; Eliane Mery; Gerlinde Avérous; Anne Chevallier; Marie-Hélène Laverriere; Irène Villa; Olivier Harou; Françoise Galateau Sallé; Laurent Villeneuve; Olivier Glehen; Sylvie Isaac; Juliette Hommell-Fontaine; Frédéric Bibeau
Journal:  Virchows Arch       Date:  2021-04-14       Impact factor: 4.064

Review 3.  B lymphocytes and cancer: a love-hate relationship.

Authors:  Grace J Yuen; Ezana Demissie; Shiv Pillai
Journal:  Trends Cancer       Date:  2016-12

4.  Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status.

Authors:  Ji Ae Lee; Seung-Yeon Yoo; Hyeon Jeong Oh; Seorin Jeong; Nam-Yun Cho; Gyeong Hoon Kang; Jung Ho Kim
Journal:  Cancer Immunol Immunother       Date:  2020-07-04       Impact factor: 6.968

5.  Differences in histological features and PD-L1 expression between sporadic microsatellite instability and Lynch-syndrome-associated disease in Japanese patients with colorectal cancer.

Authors:  Rin Yamada; Tatsuro Yamaguchi; Takeru Iijima; Rika Wakaume; Misato Takao; Koichi Koizumi; Tsunekazu Hishima; Shin-Ichiro Horiguchi
Journal:  Int J Clin Oncol       Date:  2018-01-11       Impact factor: 3.402

6.  Distinct histopathological characteristics in colorectal submucosal invasive carcinoma arising in sessile serrated adenoma/polyp and conventional tubular adenoma.

Authors:  Takashi Murakami; Hiroyuki Mitomi; Takashi Yao; Tsuyoshi Saito; Tomoyoshi Shibuya; Naoto Sakamoto; Taro Osada; Sumio Watanabe
Journal:  Virchows Arch       Date:  2017-09-19       Impact factor: 4.064

7.  Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer.

Authors:  Yoshifumi Shimada; Shujiro Okuda; Yu Watanabe; Yosuke Tajima; Masayuki Nagahashi; Hiroshi Ichikawa; Masato Nakano; Jun Sakata; Yasumasa Takii; Takashi Kawasaki; Kei-Ichi Homma; Tomohiro Kamori; Eiji Oki; Yiwei Ling; Shiho Takeuchi; Toshifumi Wakai
Journal:  J Gastroenterol       Date:  2021-04-28       Impact factor: 7.527

8.  Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers.

Authors:  Jung Ho Kim; Jeong Mo Bae; Hyeon Jeong Oh; Hye Seung Lee; Gyeong Hoon Kang
Journal:  J Pathol Transl Med       Date:  2015-03-12

9.  12-Chemokine signature, a predictor of tumor recurrence in colorectal cancer.

Authors:  Ryuma Tokunaga; Shigeki Nakagawa; Yasuo Sakamoto; Kenichi Nakamura; Madiha Naseem; Daisuke Izumi; Keisuke Kosumi; Katsunobu Taki; Takaaki Higashi; Tatsunori Miyata; Yuji Miyamoto; Naoya Yoshida; Hideo Baba; Heinz-Josef Lenz
Journal:  Int J Cancer       Date:  2020-04-25       Impact factor: 7.316

10.  Automated Quantitation of CD8-positive T Cells Predicts Prognosis in Colonic Adenocarcinoma With Mucinous, Signet Ring Cell, or Medullary Differentiation Independent of Mismatch Repair Protein Status.

Authors:  Douglas J Hartman; Madison Frank; Lindsey Seigh; Haroon Choudry; James Pingpank; Matthew Holtzman; David Bartlett; Nathan Bahary; Liron Pantanowitz; Reetesh K Pai
Journal:  Am J Surg Pathol       Date:  2020-07       Impact factor: 6.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.